Anxiolytic effects of L-theanine - A component of green tea-when combined with midazolam, in the male Sprague-Dawley rat

AANA Journal

Volumn 77, Issue 6, 2009, Pages 445-449

  Heese, Traci ^a   Jenkinson, Jack ^a   Love, Cheryl ^b   Milam, Ronald ^c   Perkins, Lillian ^d   Adams, Cynthia ^c   McCall, Suzanne ^e   Ceremuga, Thomas E ^f  

^a William Beaumont Army Medical Center ^*

^b WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^c Carl R Darnall Army Medical Center   (United States)

^d US Army Graduate Program in Anesthesia Nursing   (South Korea)

^e BROOKE ARMY MEDICAL CENTER   (United States)

^f BAYLOR UNIVERSITY   (United States)

Author keywords

Anxiolysis; Elevated plus maze; Green tea; L theanine; Rats

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; DOPAMINE; FLUMAZENIL; MIDAZOLAM; SEROTONIN; THEANINE;

ANESTHESIST; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; HERBAL MEDICINE; MALE; MAZE TEST; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; NONHUMAN; PERIOPERATIVE PERIOD; POST HOC ANALYSIS; RAT; SPRAGUE DAWLEY RAT; TEA; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CAMELLIA SINENSIS; DRUG SYNERGISM; GLUTAMATES; MALE; MAZE LEARNING; MIDAZOLAM; MULTIVARIATE ANALYSIS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 74049086150     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. US Surgeon General. Anxiety disorders. In: Adults and mental health. Mental Health: A Report of the US Surgeon General. 2006. http://www. surgeongeneral.gov/library/mentalhealth/chapter4/sec2.html. Accessed September 23, 2009.
2. Anxiety attacks and disorders: guide to the signs, symptoms, and treatment options. http://www.helpguide.org/mental/anxiety-types-symptoms- treatment.htm. Accessed September 23, 2009.
3. Selye H. Further thoughts on 'stress without distress'. Med Times. 1976;104(11):124-144.
4. Bauer KP, Dom PM, Ramirez AM, O'Flaherty JE. Preoperative intravenous midazolam: benefits beyond anxiolysis. J Clin Anesth. 2004; 16(3):177-183.
5. Egbert LD, Battit GE, Welch CE, Bartlett MK. Reduction of postoperative pain by encouragement and instruction of patients: a study of doctor-patient rapport. N Engl J Med. 1964;270:825-827.
6. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by U.S. adults: 1997-2002. Alternative Ther Health Med. 2005;11(1):42-49.
7. Brasfield K. Dietary supplement intake in the active duty enlisted population. US Army Med Dept J. 2004; PB 8-04-10/11/12, 44-55.
8. Tsen LC, Segal S, Pothier M, Bader AM. Alternative medicine use in presurgical patients. Anesthesiology. 2000;93(1):148-151.
9. Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complementary Ther Med. 2006;12(2-3):90-98.
10. Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women's views, knowledge and interaction with doctors: a qualitative study. BMC Complementary Alternative Med. 2006;6:40.
11. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286(2):208-216.
12. Juneja LR, Chu DC, Okubo T, Nagato Y, Yokogoshi H. L-theanine - a unique amino acid of green tea and its relaxation effect in humans. Trends Food Sci Technol. 1999; 10(6): 199-204.
13. Eschenauer G, Sweet BV. Pharmacology and therapeutic uses of theanine. Am J Health Syst Pharmacol 2006;63(1):26-30.
14. Charney DS, Mihic SJ, Harris RA. Hypnotics and sedatives. In: Hardman JG, Limbird LE. Goodman & Gilman's The Pharmacologic Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:402-406.
15. Lu K, Gray MA, Oliver C, et al. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans, hum Psychopharmacol. 2004;19(7):457-465.
16. Sugiyama T, Sadzuka Y. Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma. Clin Cancer Res. 1999;5(2):413-416.
17. Nutt DJ, Malizia AL. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 2001; 179:390-396. (Pubitemid 33097160)
18. Pellow S, Chopin P, File SE, Briley M. Validation of openxlosed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14(3):149-167. (Pubitemid 16239568)
19. Montgomery KC The relation between fear induced by novel stimulation and exploratory behavior. J Compr Physiol Psychol. 1955;48(4): 254-260.
20. Yokogoshi H, Kobayashi M, Mochizuki M, Terashima T. Effect of theanine, r-glutamylethylamide, on brain monamines and striatal dopamine release in conscious rats. Neurochem Res. 1998;23(5):667-673.
21. Yokogoshi H, Mochizuki M, Saitoh K. Theanine-induced reduction of brain serotonin concentration in rats. Biosci Biotechnol Biochem, 1998; 62(4):816-817.
22. Yokogoshi H, Terashima T. Effect of theanine, r-glutamylethylamide, on brain monoamines, striatal dopamine release and some kinds of behavior in rats. Nutrition. 2000;16(9):776-777.